pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keynote,671', 'keytruda', 'pembro', 'keynote-671', 'key,note,42', 'merck']
more news from #asco23! 1 merck's keytruda (pembrolizumab) combined with chemotherapy reduced the risk of event-free survival (efs) by an impressive 42% against pre-operative chemotherapy alone in the keynote-671 trial for patients with resectable s 
Strategy & Competitive Marketing | Digital & Social Pharma | Life Sciences Investment | Cell & Gene Therapy | Vaccines